---
figid: PMC10531820__ijms-24-14114-g006
figtitle: Regulatory T Cells in Cancer Treatment Resistance
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC10531820
filename: ijms-24-14114-g006.jpg
figlink: /pmc/articles/PMC10531820/figure/ijms-24-14114-f006/
number: F6
caption: PD-1/PD-L1 axis affects Tregs and Teffs through different mechanisms. NOTCH
  pathway activation and AEP inactivation induce Tregs immunosuppressive activity.
  Downregulation of AKT, mTOR, ERK2, and upregulation of PTEN mediates the conversion
  of the naïve CD4+ T cells into Tregs. Moreover, blockade of PD-1/PD-L1 interaction
  can increase Teffs proliferation and restore their secretory function. AEP, asparaginyl
  endopeptidase; Akt, cellular homolog of murine thymoma virus Akt8 oncogene; anti-PD-1/PD-L1
  Ab, anti-PD-1/PD-L1 antibody; ERK2, extracellular-signal-regulated kinase 2; mTOR,
  mammalian target of rapamycin; PD-1, programmed cell death; PD-L1, programmed cell
  death ligand; PTEN, phosphatase and tensin homolog deleted on chromosome 10; Teff,
  effector T cell; TIL, tumor-infiltrated T cell; Treg, regulatory T cell.
papertitle: The Role of Regulatory T Cells in Cancer Treatment Resistance.
reftext: Anna Dąbrowska, et al. Int J Mol Sci. 2023 Sep;24(18):14114.
year: '2023'
doi: 10.3390/ijms241814114
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: regulatory T cell | resistance mechanisms | immunotherapy | chemotherapy
  | radiotherapy
automl_pathway: 0.9249722
figid_alias: PMC10531820__F6
figtype: Figure
redirect_from: /figures/PMC10531820__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10531820__ijms-24-14114-g006.html
  '@type': Dataset
  description: PD-1/PD-L1 axis affects Tregs and Teffs through different mechanisms.
    NOTCH pathway activation and AEP inactivation induce Tregs immunosuppressive activity.
    Downregulation of AKT, mTOR, ERK2, and upregulation of PTEN mediates the conversion
    of the naïve CD4+ T cells into Tregs. Moreover, blockade of PD-1/PD-L1 interaction
    can increase Teffs proliferation and restore their secretory function. AEP, asparaginyl
    endopeptidase; Akt, cellular homolog of murine thymoma virus Akt8 oncogene; anti-PD-1/PD-L1
    Ab, anti-PD-1/PD-L1 antibody; ERK2, extracellular-signal-regulated kinase 2; mTOR,
    mammalian target of rapamycin; PD-1, programmed cell death; PD-L1, programmed
    cell death ligand; PTEN, phosphatase and tensin homolog deleted on chromosome
    10; Teff, effector T cell; TIL, tumor-infiltrated T cell; Treg, regulatory T cell.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ab
  - Appl
  - Akt
  - Mtor
  - Tor
  - p38a
  - Pten
  - IL2
  - TLR1
  - APP
  - SUCLA2
  - CD274
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - CD4
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - LGMN
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - MAPK1
  - PTEN
---
